Caption Management
CORV

Caption Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Caption Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-111,500
Closed -$278K – 788
2018
Q4 		$278K Hold
111,500
– – 0.02% 386
2018
Q3 		$448K Buy
+111,500
New +$492K 0.02% 420

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Clough Capital Partners
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
Putnam Investments
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Rock Springs Capital Management
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ARS Investment Partners
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Caption Management's CORV Position: Q1 2019 in Review

Caption Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2019, closing a stake of 111,500 shares — an estimated $278K sold.

Caption Management first reported a position in CORV in Q3 2018 and held it in 2 quarters. The position peaked at $448K in Q3 2018. 40 funds tracked by Wall St. Rank hold CORV as of Q1 2019.

  • Caption Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2019 after selling out during the quarter.
  • Caption Management sold 111,500 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2019, an estimated $278K.
  • Caption Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2018 and held it in 2 quarters.
  • Caption Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $448K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2019.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.